New frontiers in the management of chemotherapy-induced mucositis
- PMID: 9801855
New frontiers in the management of chemotherapy-induced mucositis
Abstract
About one-third of patients undergoing chemotherapy treatment suffer oral mucositis, an inflammatory-like change of the oral mucosa. Severe pseudomembranous/ulcerative mucositis can lead to secondary infection of lesions, sepsis and even cessation of treatment. Patients receiving curative head-neck irradiation are most susceptible and children undergoing chemotherapy are three times more likely to be affected. Mucositis is a costly side-effect of cancer therapy due to the extra time patients spend in hospital and currently there is no consistently effective treatment. Experimental studies with TGF-beta 3, a potent negative regulator of epithelial and haematopoietic stem cell growth, have shown that it is possible to temporarily arrest oral mucosal basal cell proliferation, and could therefore offer a new effective and safe form of preventative intervention for patients about to undergo aggressive regimens of cancer therapy.
Similar articles
-
Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3.Cancer Res. 1994 Mar 1;54(5):1135-8. Cancer Res. 1994. PMID: 8118793
-
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.Oncol Rep. 2003 Jan-Feb;10(1):197-206. Oncol Rep. 2003. PMID: 12469169 Clinical Trial.
-
[Prevention and treatment of mucositis from cytotoxic chemotherapy].Clin Ter. 2002 Mar-Apr;153(2):127-34. Clin Ter. 2002. PMID: 12078338 Review. Italian.
-
Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.Minerva Stomatol. 2002 May;51(5):173-86. Minerva Stomatol. 2002. PMID: 12070468 Review.
-
Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters.Cytokine. 1997 Aug;9(8):605-12. doi: 10.1006/cyto.1997.0208. Cytokine. 1997. PMID: 9245489
Cited by
-
Chemotherapy-induced oral mucositis. Prevention and management.Drugs Aging. 2000 Oct;17(4):257-67. doi: 10.2165/00002512-200017040-00002. Drugs Aging. 2000. PMID: 11087004 Review.
-
Development and initial evaluation of electronic Children's International Mucositis Evaluation Scale (eChIMES) for children with cancer.Support Care Cancer. 2014 Jan;22(1):115-9. doi: 10.1007/s00520-013-1953-x. Epub 2013 Sep 3. Support Care Cancer. 2014. PMID: 24000043
-
Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling.Br J Cancer. 2002 Jul 1;87(1):113-8. doi: 10.1038/sj.bjc.6600342. Br J Cancer. 2002. PMID: 12085266 Free PMC article.
-
A survey of chinese medicinal herbal treatment for chemotherapy-induced oral mucositis.Evid Based Complement Alternat Med. 2013;2013:284959. doi: 10.1155/2013/284959. Epub 2013 Oct 28. Evid Based Complement Alternat Med. 2013. PMID: 24285975 Free PMC article. Review.